Chemical recycling and what it means for Ontario Blue Box programs

| May 3, 2019

article image
The Ontario government in its recent discussion paper: Reducing litter and waste in our communities offered the following: “The increased use of chemical recycling could be used to improve the effectiveness of existing recycling processes and to enable economic growth by expanding the potential end uses for materials that currently are sent to landfill.”  This blog, prepared by Dan Lantz of Crows Nest Environmental, looks at chemical recycling and the technological developments taking place around the world.

Spotlight

Seattle Genetics

Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. The largest global oncology biotechnology company based in the Pacific Northwest, we are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients.

OTHER ARTICLES

Ensuring a Winning Strategy for Value Chain Optimization of the Refining and Petrochemical Industries

Article | March 24, 2020

The Refining and petrochemical industries have a projection to keep growing in the next two decades and companies that are investing in new technology today will be ahead of your competition in about 2 years. The digitalization of the value chain, also known as value chain optimization, is a complex task. Part of this complexity comes from the diversity of challenges that occurs in different areas of the value chain within each operation, as we addressed in the article Understanding the Refining and Petrochemical Value Chains to Drive Optimization. Many companies still fail to obtain economic return from their investment in digitalization and we presented the most common challenges in the article Challenges of Achieving Value Chain Optimization in the Refining and Petrochemical Industries. With so many challenges, how can businesses ensure they have a strategic digital transformation program that will successfully result in the optimization of your value chain?

Read More

The Trump EPA’s “Working Approach” to new chemical reviews is only working for the chemical industry

Article | February 23, 2020

The Trump EPA has worked very hard to render this long-awaited update of its approach to reviewing new chemicals under TSCA an empty exercise. Despite Administrator Wheeler’s promises in January 2019 to the contrary: EPA has still failed to provide any legal or scientific justification for its Working Approach. EPA provided no actual response to the many detailed comments it received on its 2017 framework, instead issuing a 1.5-page document that dismisses many of the comments merely as having “stemmed from a misunderstanding of the Agency’s intent.”

Read More

The supply-chain inflation threat to petrochemicals demand

Article | May 9, 2021

Petrochemicals themselves remain in short supply. This is partly because of reduced feedstock from refineries, a consequence of the pandemic-related collapse in transportation fuels demand.Global petrochemical supply is still edging back to something like normal following the US winter storms in February, during which most US capacity was shut down. A point of discussion is whether containers will become available in the right places at the right prices to relieve tightness in the European polyethylene (PE) market, once US supply has normalised. The container issue is making it difficult to move PE and polypropylene (PP) cargoes from Asia to Europe.Market intelligence from the US-based ICIS CDI team indicates that enough container freight space will be available to resume significant shipments of US PE to Europe, albeit at high prices. It will be several more weeks before domestic pipelines have been refilled, enabling US producers to refocus on exports, added CDI.

Read More

Taiwan Amends the Toxic Chemical Substance Operators Liability Insurance Measures

Article | March 1, 2020

Taiwan amended the Toxic Chemical Substances Operation Liability Insurance Measures and renamed it the Toxic and Concerned Chemical Substance Operators Liability Insurance Measures. The Measures require operators to obtain liability insurance before operation if the total amount during the manufacture, use, storage, and transportation of toxic chemicals of the first to third categories or hazardous chemical substances of concern reach a specified benchmark.

Read More

Spotlight

Seattle Genetics

Seattle Genetics is dedicated to improving patient outcomes through advanced antibody-drug conjugate technology designed to deliver cell-killing agents directly to tumor cells. The largest global oncology biotechnology company based in the Pacific Northwest, we are focused on developing and commercializing a new generation of targeted, empowered antibody-based therapies that have the potential to change the foundation of treatment for people with cancer. Our industry-leading antibody-drug conjugate (ADC) technology combines the specificity of monoclonal antibodies, innovative linker systems, and the power of potent cell-killing agents to treat cancer. Using our proprietary technology, we are able to optimize each ADC to potentially improve outcomes for patients.

Events